Trendspotting: What’s Coming for Diagnostics in 2024

“I foresee newborn screening (NBS) will be a game changer in 2024. Expanded NBS systems will usher in a new era of large-scale correlations between screened healthy and unhealthy individuals. It will produce even more genome sequencing data from which we can draw meaningful and potentially surprising correlations to diagnose patients earlier and match them to the most appropriate treatments,” said Mark Kiel of Genomenon. Continue Reading…